All news

Director Sangeeta N. Bhatia proposes selling 271 Vertex Pharmaceuticals (VRTX) shares.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Sangeeta N. Bhatia, a director at Vertex Pharmaceuticals Inc. (VRTX), has filed a notice to sell 271 common shares, valued at approximately

Read original source

VRTX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.